PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma

Summary

Given the growing importance of anti-angiogenic therapies in the treatment of metastatic renal carcinoma, it is expected that this trial will establish the preliminary data needed to apply for funding of a larger clinical investigation of the potential role of PET perfusion imaging in management of renal carcinoma, and potentially other cancers.

Timeline

Start

2011-10

Primary completion

2014-02

Completion

2014-02

Drugs

Indications